Makers of Humira and Enbrel Using New Drug Patents to Delay Generic Versions
Monday, July 18, 2016 - 09:11
in Health & Medicine
Six years after the Affordable Care Act cleared the way for biosimilars, as the generic versions of biotechnology drugs are called, progress has been slow.